10,000 results · 79ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ARGYLE

FDA Adverse Event
Malfunction ·CARDINAL HEALTH, INC.·Product code LJS·April 3, 2026

SPECTRUM TURBO-JECT ANTIBIOTIC POWER INJECTABLE PICC

FDA Adverse Event
Injury ·COOK INC·Product code LJS·December 22, 2021

SPECTRUM TURBO-JECT ANTIBIOTIC POWER INJECTABLE PICC

FDA Adverse Event
Injury ·COOK INC·Product code LJS·July 1, 2017

ARGYLE

FDA Adverse Event
Malfunction ·CARDINAL HEALTH, INC.·Product code LJS·April 2, 2026

Catheter, intravascular, therapeutic, short-term less than 30 days

FDA Adverse Event
Malfunction ·COOK INC·Product code FOZ·November 10, 2022

ARGYLE

FDA Adverse Event
Malfunction ·CARDINAL HEALTH, INC.·Product code LJS·April 7, 2026

ARGYLE

FDA Adverse Event
Malfunction ·CARDINAL HEALTH, INC.·Product code LJS·March 2, 2026

ARGYLE

FDA Adverse Event
Malfunction ·CARDINAL HEALTH, INC.·Product code LJS·February 12, 2026

BD PRECISIONGLIDE¿ NEEDLE

FDA Adverse Event
Malfunction ·BD MEDICAL (BD WEST) MEDICAL SURGICAL·Product code FMI·December 14, 2017

ARGYLE

FDA Adverse Event
Malfunction ·CARDINAL HEALTH, INC.·Product code LJS·February 12, 2026

ARGYLE

FDA Adverse Event
Malfunction ·CARDINAL HEALTH, INC.·Product code LJS·February 12, 2026

ABBOCATH-T 20G 1-1/4

FDA Adverse Event
Malfunction ·AMSINO MEDICAL CO., LTD·Product code FOZ·April 27, 2009

INSYTE AUTOGUARD PNK 20GA X 1.16IN

FDA Adverse Event
Malfunction ·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FOZ·November 14, 2019

ARGYLE

FDA Adverse Event
Malfunction ·CARDINAL HEALTH, INC·Product code LJS·October 21, 2025

BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER

FDA Adverse Event
Malfunction ·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FOZ·June 25, 2019

BD NEXIVA¿ SINGLE PORT WITH MAXZERO¿ CLOSED IV CATHETER

FDA Adverse Event
Malfunction ·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FPA·March 8, 2023

ARROW, ARROWG+ARD AND ARROWG+ARD BLUE PLUS PRESSURE INJECTABLE CENTRAL VENOUS CATHETER. Product Usage: Indicated to provide short-term (<30 days) central venous access for treatment of diseases or conditions requiring cental venous access including, but not limited to: multiple infusions of fluids, medications, or chemotherapy, infusion of fluids that are hypertonic, hyperosmolar, or have divergent pH values, frequent blood sampling or blood/blood component infusions, infusion of incompatible medications, central venous pressure monitoring, lack of usable peripheral IV sites, replacement of multiple peripheral sites for IV access and injection of contrast media.

FDA Enforcement
Class II ·Terminated·Arrow International Inc·July 13, 2016

BD INSYTE¿ AUTOGUARD¿ SHIELDED IV CATHETER

FDA Adverse Event
Malfunction ·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FOZ·June 6, 2022

BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER

FDA Adverse Event
Malfunction ·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FOZ·June 26, 2019

VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT

FDA Adverse Event
Malfunction ·ETHICON INC.·Product code GAM·April 21, 2020